CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Eli Lilly CEO: Competition in Pharma | Mad Money | CNBC
Posted
December 20, 2018
Views
6,414
Likes
39
Comments
18
Engagement
0.89%
December 20, 2018
6,414
39
18
0.89%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:24
9:11Now PlayingAll eyes are on Eli Lilly, with shares moving higher after the company updated its 2019 guidance. Can the move continue? Jim Cramer gets the latest from CEO Dave Ricks.
» Subscribe to CNBC
» Watch more Mad Money here
» Read more about Eli Lilly here
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news
Watch full episodes
Follow Mad Money on Twitter
Like Mad Money on Facebook
Follow Cramer on Twitter
Connect with CNBC News Online!
Visit CNBC.com
Find CNBC News on Facebook
Follow CNBC News on Twitter
Follow CNBC News on Google+
Follow CNBC News on Instagram
Eli Lilly CEO: Competition in Pharma | Mad Money | CNBC
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
